These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 23948876

  • 21. Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men.
    Evans SF, Davie MW.
    Ann Rheum Dis; 2000 Apr; 59(4):269-75. PubMed ID: 10733473
    [Abstract] [Full Text] [Related]

  • 22. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
    Rayar MS, Nayiager T, Webber CE, Barr RD, Athale UH.
    Pediatr Blood Cancer; 2012 Jul 15; 59(1):77-82. PubMed ID: 22190454
    [Abstract] [Full Text] [Related]

  • 23. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
    Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC, Espinosa G, Gómez-Puerta JA, Monegal A, Guañabens N, Peris P.
    Rheumatology (Oxford); 2020 Jul 01; 59(7):1574-1580. PubMed ID: 31628810
    [Abstract] [Full Text] [Related]

  • 24. Vertebral Body Reshaping after Fractures: An Important Index of Recovery in Glucocorticoid-Treated Children.
    Ma J, Siminoski K, Jaremko JL, Koujok K, Matzinger MA, Shenouda N, Wilson N, Cheng M, Alos N, Atkinson S, Cummings EA, Ho J, Rodd C, Sbrocchi AM, Stein R, Barr R, Cairney E, Dix DB, Fernandez CV, Grant R, Halton J, Israels S, Laverdière C, Lewis VA, Cabral DA, Huber A, Houghton K, Jurencak R, Lang B, Larché M, LeBlanc CMA, Miettunen P, Roth J, Scuccimarri R, Bell L, Blydt-Hansen T, Filler G, Feber J, Phan V, Smit K, Rauch F, Ward LM.
    J Clin Endocrinol Metab; 2024 Feb 20; 109(3):e1225-e1237. PubMed ID: 37843393
    [Abstract] [Full Text] [Related]

  • 25. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
    Geneviève N, Mojgan Y, Nahid Y, Vincenzo F, Simon G, Daniel S, Maja K, Nathalie A, Despoina M.
    J Bone Miner Res; 2024 Mar 22; 39(2):130-138. PubMed ID: 38477791
    [Abstract] [Full Text] [Related]

  • 26. Anatomical distribution of vertebral fractures: comparison of pediatric and adult spines.
    Siminoski K, Lee KC, Jen H, Warshawski R, Matzinger MA, Shenouda N, Charron M, Coblentz C, Dubois J, Kloiber R, Nadel H, O'Brien K, Reed M, Sparrow K, Webber C, Lentle B, Ward LM, STOPP Consortium.
    Osteoporos Int; 2012 Jul 22; 23(7):1999-2008. PubMed ID: 22109742
    [Abstract] [Full Text] [Related]

  • 27. Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
    Roux C, Reid DM, Devogelaer JP, Saag K, Lau CS, Reginster JY, Papanastasiou P, Bucci-Rechtweg C, Su G, Sambrook PN.
    Osteoporos Int; 2012 Mar 22; 23(3):1083-90. PubMed ID: 21975559
    [Abstract] [Full Text] [Related]

  • 28. The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures.
    Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M, Shenouda N, Atkinson S, Barr R, Cabral DA, Couch R, Cummings EA, Fernandez CV, Grant RM, Rodd C, Sbrocchi AM, Scharke M, Rauch F, Ward LM, Canadian STOPP Consortium.
    J Clin Endocrinol Metab; 2015 Mar 22; 100(3):1018-27. PubMed ID: 25494661
    [Abstract] [Full Text] [Related]

  • 29. Nonstandard Lumbar Region in Predicting Fracture Risk.
    Alajlouni D, Bliuc D, Tran T, Pocock N, Nguyen TV, Eisman JA, Center JR.
    J Clin Densitom; 2018 Mar 22; 21(2):220-226. PubMed ID: 28689879
    [Abstract] [Full Text] [Related]

  • 30. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD, Martineau P, Bryanton M, Lix LM.
    Osteoporos Int; 2019 Jul 22; 30(7):1445-1453. PubMed ID: 31016351
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    Calcif Tissue Int; 2000 Mar 22; 66(3):195-9. PubMed ID: 10666494
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Accuracy of Prevalent Vertebral Fracture Detection in Children Using Targeted Case-Finding Approaches.
    Ma J, Siminoski K, Wang P, Alos N, Cummings EA, Feber J, Halton J, Ho J, Houghton K, Lang B, Miettunen PM, Scuccimarri R, Jaremko JL, Koujok K, Lentle B, Matzinger MA, Shenouda N, Rauch F, Ward LM, the Canadian Steroid-Induced Osteoporosis in the Pediatric Population (STOPP) ConsortiumCanadian Pediatric Bone Health Working Group, Ottawa, ON, Canada..
    J Bone Miner Res; 2020 Mar 22; 35(3):460-468. PubMed ID: 31742768
    [Abstract] [Full Text] [Related]

  • 35. Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Park SY, Ahn SH, Bae GH, Jang S, Kwak MK, Kim HY, Kim SH, Epidemiology Committee of the Korean Society of Bone Metabolism.
    Osteoporos Int; 2024 Oct 22; 35(10):1779-1787. PubMed ID: 38953946
    [Abstract] [Full Text] [Related]

  • 36. Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.
    Ma J, Siminoski K, Alos N, Halton J, Ho J, Cummings EA, Shenouda N, Matzinger MA, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis VA, Laverdière C, Israels S, Grant RM, Fernandez CV, Dix DB, Couch R, Cairney E, Barr R, Atkinson S, Abish S, Moher D, Rauch F, Ward LM, Canadian STOPP Consortium.
    J Clin Endocrinol Metab; 2019 Feb 01; 104(2):213-222. PubMed ID: 30247635
    [Abstract] [Full Text] [Related]

  • 37. Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy.
    Phung K, McAdam L, Ma J, McMillan HJ, Jackowski S, Scharke M, Matzinger MA, Shenouda N, Koujok K, Jaremko JL, Wilson N, Walker S, Hartigan C, Khan N, Page M, Robinson ME, Saleh DS, Smit K, Rauch F, Siminoski K, Ward LM.
    J Clin Endocrinol Metab; 2024 Jan 18; 109(2):536-548. PubMed ID: 37610420
    [Abstract] [Full Text] [Related]

  • 38. The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Zhukouskaya VV, Eller-Vainicher C, Gaudio A, Privitera F, Cairoli E, Ulivieri FM, Palmieri S, Morelli V, Grancini V, Orsi E, Masserini B, Spada AM, Fiore CE, Chiodini I.
    Osteoporos Int; 2016 Jan 18; 27(1):49-56. PubMed ID: 26138582
    [Abstract] [Full Text] [Related]

  • 39. The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
    Padlina I, Gonzalez-Rodriguez E, Hans D, Metzger M, Stoll D, Aubry-Rozier B, Lamy O.
    Osteoporos Int; 2017 Mar 18; 28(3):909-915. PubMed ID: 27900426
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.